Standard BioTools, Inc. (LAB)
NASDAQHealth CareMedical - SpecialtiesSnapshot 2026-11-04
$0.62+0.85%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - SpecialtiesSnapshot 2026-11-04
QuarterlyIQ Insights · LAB
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance dropped from the top half to the bottom half of its industry over the past month — the reason to own it has weakened.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -53.1% |
| Our one-year growth estimate | diamond | -2.4% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 50.7 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 1 industry peers · Company calendar date is not available
LAB — litigation filed
Dated 2026-11-03
and in the attached Exhibit 99.1 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. Forward-Looking Statements This Current Report on Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigatio…
Why it matters: The sale is part of the Treeline transaction plan. Closing would bring in $5.5 million in cash and avoid a $10 million loan.
Watch forThe company reports that the Element sale closed by Dec. 31, 2026, for about $5.5 million in cash.
Also watch forThe sale does not close by Dec. 31, 2026, or the agreement is ended.
Why it matters: The merger is tied to the company's plan to close by year-end. A failed vote or delay would put that plan at risk.
Watch forStockholders approve the Treeline merger, and the company reports closing by Dec. 31, 2026.
Also watch forStockholders reject the merger, or the company reports that it will not close by Dec. 31, 2026.
Why it matters: Q2 revenue fell 7.6% to $20.1 million. The next report can show whether sales and cash use are getting better or worse.
Watch forIn the Nov. 3 report, quarterly revenue is above $20.1 million and adjusted EBITDA loss is below $2.5 million.
Also watch forIn the Nov. 3 report, quarterly revenue is below $20.1 million or adjusted EBITDA loss is above $2.5 million.
Why it matters: The sale is another step in the company's stated plan to reshape its business. A delay or failed deal would leave that step incomplete.
Watch forThe company reports that the ARCHIMED sale closed on the terms in the Oct. 5 agreement.
Also watch forThe company reports that the deal ended, or it remains unclosed after Nov. 30, 2026.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$225 on $10,000 · ±2.2% | How much price usually moves either way. |
| Bad day | $571 loss on $10,000 · 5.7% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $6,429 loss on $10,000 · 64.3% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.